A detailed history of State Board Of Administration Of Florida Retirement System transactions in Charles River Laboratories International, Inc. stock. As of the latest transaction made, State Board Of Administration Of Florida Retirement System holds 46,941 shares of CRL stock, worth $8.82 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares
46,941
Previous 46,941 -0.0%
Holding current value
$8.82 Million
Previous $9.7 Million 4.65%
% of portfolio
0.02%
Previous 0.02%

Shares

30 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 08, 2024

SELL
$206.39 - $268.73 $2.04 Million - $2.66 Million
-9,899 Reduced 17.42%
46,941 $9.7 Million
Q1 2024

May 08, 2024

BUY
$203.52 - $273.43 $557,441 - $748,924
2,739 Added 5.06%
56,840 $15.4 Million
Q4 2023

Feb 09, 2024

BUY
$164.52 - $238.84 $581,742 - $844,538
3,536 Added 6.99%
54,101 $12.8 Million
Q3 2023

Nov 08, 2023

SELL
$194.44 - $217.61 $701,928 - $785,572
-3,610 Reduced 6.66%
50,565 $9.91 Million
Q2 2023

Aug 11, 2023

SELL
$183.71 - $210.25 $489,587 - $560,316
-2,665 Reduced 4.69%
54,175 $11.4 Million
Q1 2023

Jun 14, 2023

SELL
$191.89 - $259.92 $314,699 - $426,268
-1,640 Reduced 2.8%
56,840 $11.5 Million
Q1 2023

May 11, 2023

SELL
$191.89 - $259.92 $314,699 - $426,268
-1,640 Reduced 2.8%
56,840 $11.5 Million
Q4 2022

Jun 14, 2023

BUY
$197.11 - $250.07 $323,260 - $410,114
1,640 Added 2.89%
58,480 $12.7 Million
Q4 2022

Feb 07, 2023

BUY
$197.11 - $250.07 $15,768 - $20,005
80 Added 0.14%
58,480 $12.7 Million
Q3 2022

Nov 08, 2022

BUY
$182.44 - $250.54 $46,522 - $63,887
255 Added 0.44%
58,400 $11.5 Million
Q2 2022

Aug 05, 2022

SELL
$204.13 - $302.4 $221,276 - $327,801
-1,084 Reduced 1.83%
58,145 $12.4 Million
Q1 2022

May 06, 2022

SELL
$255.51 - $362.11 $511,020 - $724,220
-2,000 Reduced 3.27%
59,229 $16.8 Million
Q4 2021

Feb 08, 2022

SELL
$351.38 - $448.68 $279,698 - $357,149
-796 Reduced 1.28%
61,229 $23.1 Million
Q3 2021

Nov 08, 2021

BUY
$372.64 - $458.3 $247,432 - $304,311
664 Added 1.08%
62,025 $25.6 Million
Q2 2021

Aug 10, 2021

SELL
$294.17 - $371.65 $761,311 - $961,830
-2,588 Reduced 4.05%
61,361 $22.7 Million
Q1 2021

May 10, 2021

SELL
$249.67 - $299.48 $706,566 - $847,528
-2,830 Reduced 4.24%
63,949 $18.5 Million
Q4 2020

Feb 08, 2021

SELL
$222.0 - $252.62 $233,322 - $265,503
-1,051 Reduced 1.55%
66,779 $16.7 Million
Q3 2020

Nov 09, 2020

SELL
$175.56 - $226.45 $1.24 Million - $1.59 Million
-7,038 Reduced 9.4%
67,830 $15.4 Million
Q2 2020

Aug 07, 2020

SELL
$118.84 - $189.72 $43,138 - $68,868
-363 Reduced 0.48%
74,868 $13.1 Million
Q1 2020

May 05, 2020

BUY
$98.9 - $178.34 $301,150 - $543,045
3,045 Added 4.22%
75,231 $9.5 Million
Q4 2019

Feb 03, 2020

BUY
$126.05 - $152.76 $245,797 - $297,882
1,950 Added 2.78%
72,186 $11 Million
Q3 2019

Nov 07, 2019

BUY
$125.07 - $143.67 $89,425 - $102,724
715 Added 1.03%
70,236 $9.3 Million
Q2 2019

Aug 05, 2019

SELL
$123.4 - $148.55 $101,681 - $122,405
-824 Reduced 1.17%
69,521 $9.87 Million
Q1 2019

May 03, 2019

SELL
$104.82 - $146.73 $125,783 - $176,076
-1,200 Reduced 1.68%
70,345 $10.2 Million
Q4 2018

Feb 01, 2019

SELL
$105.09 - $137.23 $212,071 - $276,930
-2,018 Reduced 2.74%
71,545 $8.1 Million
Q3 2018

Oct 31, 2018

SELL
$112.11 - $134.54 $1.02 Million - $1.22 Million
-9,056 Reduced 10.96%
73,563 $9.9 Million
Q2 2018

Aug 06, 2018

BUY
$102.37 - $117.25 $36,238 - $41,506
354 Added 0.43%
82,619 $9.28 Million
Q1 2018

May 04, 2018

SELL
$98.19 - $115.2 $675,449 - $792,460
-6,879 Reduced 7.72%
82,265 $8.78 Million
Q4 2017

Feb 01, 2018

BUY
$100.43 - $118.09 $133,170 - $156,587
1,326 Added 1.51%
89,144 $9.76 Million
Q3 2017

Oct 31, 2017

BUY
$96.72 - $109.26 $8.49 Million - $9.59 Million
87,818
87,818 $9.49 Million

Others Institutions Holding CRL

About CHARLES RIVER LABORATORIES INTERNATIONAL, INC.


  • Ticker CRL
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 50,863,300
  • Market Cap $9.56B
  • Description
  • Charles River Laboratories International, Inc., a non-clinical contract research organization, provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. It operates through three segments: Research Models and Services (RMS), Discovery and Safety Ass...
More about CRL
Track This Portfolio

Track State Board Of Administration Of Florida Retirement System Portfolio

Follow State Board Of Administration Of Florida Retirement System and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of State Board Of Administration Of Florida Retirement System, based on Form 13F filings with the SEC.

News

Stay updated on State Board Of Administration Of Florida Retirement System with notifications on news.